betamethasone valerate 1.2 MG/ML Topical Foam
betamethasone valerate
RxCUI: 1244634
What the CMS Formulary Data Shows for betamethasone valerate 1.2 MG/ML Topical Foam
Per the CMS 2026 Part D formulary file, betamethasone valerate 1.2 MG/ML Topical Foam (RxNorm concept RXCUI 1244634, generic name betamethasone valerate) appears on 25 distinct formulary files spanning 369 Medicare Part D plan offerings - 7.3% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 1 to Tier 4, with a cross-plan average of Tier 2.6.
Real-world access to betamethasone valerate 1.2 MG/ML Topical Foam depends on utilization management as much as tier placement: 0% of covering formularies require prior authorization. 0% require step therapy. 4% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 145,618 Part D beneficiaries filled betamethasone valerate 1.2 MG/ML Topical Foam in 2023, with total plan-and-beneficiary spending of $10,025,188 and an average per-beneficiary annual cost of $68.85. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry betamethasone valerate 1.2 MG/ML Topical Foam today.
Coverage Details
- Formularies covering
- 25
- Plans covering
- 369
- Coverage rate
- 7.3%
- Tier range
- Tier 1 – Tier 4
- Average tier
- Tier 3, Preferred Brand
Restrictions
- Prior authorization required
- 0% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 4% of formularies
2023 Medicare Spending
- Beneficiaries
- 145,618
- Total spending
- $10,025,188
- Avg per beneficiary
- $68.85
Tier Distribution Across Plans
Medicare Advantage Plans (MA-PD) Covering betamethasone valerate 1.2 MG/ML Topical Foam
100 Medicare Advantage plans with Part D drug coverage include this drug.
Frequently Asked Questions
Is betamethasone valerate 1.2 MG/ML Topical Foam covered by Medicare Part D?
Yes, betamethasone valerate 1.2 MG/ML Topical Foam is covered by 369 Medicare Part D plans (7.3% of all Part D formularies).
What tier is betamethasone valerate 1.2 MG/ML Topical Foam on Medicare Part D plans?
betamethasone valerate 1.2 MG/ML Topical Foam averages Tier 2.6 across Part D plans, ranging from Tier 1 to Tier 4.
Does betamethasone valerate 1.2 MG/ML Topical Foam require prior authorization?
0% of Part D formularies require prior authorization for betamethasone valerate 1.2 MG/ML Topical Foam. Step therapy: 0%. Quantity limits: 4%.
How much does Medicare spend on betamethasone valerate 1.2 MG/ML Topical Foam?
In 2023, total Medicare Part D spending on betamethasone valerate 1.2 MG/ML Topical Foam was $10,025,188, covering 145,618 beneficiaries. The average spend per beneficiary was $68.85.
Read our methodology - how this data is sourced, computed, and verified.